IperionX (NASDAQ:IPX) Reaches New 1-Year Low – Should You Sell?

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report) hit a new 52-week low on Friday . The company traded as low as $20.05 and last traded at $20.64, with a volume of 365989 shares changing hands. The stock had previously closed at $21.58.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on IPX shares. Alliance Global Partners reissued a “buy” rating on shares of IperionX in a research report on Tuesday, April 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a research note on Friday, July 17th. Roth Capital set a $53.00 target price on shares of IperionX in a report on Wednesday, August 5th. Finally, BTIG Research raised their target price on shares of IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, June 5th. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, IperionX currently has an average rating of “Moderate Buy” and an average target price of $53.33.

Check Out Our Latest Analysis on IperionX

IperionX Stock Down 4.4%

The business’s 50 day moving average is $25.57 and its 200 day moving average is $32.94. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03.

Insiders Place Their Bets

In related news, Chairman Todd Hannigan purchased 300,000 shares of IperionX stock in a transaction dated Monday, July 13th. The stock was purchased at an average cost of $3.59 per share, with a total value of $1,077,000.00. Following the transaction, the chairman owned 26,633,334 shares in the company, valued at approximately $95,613,669.06. The trade was a 1.14% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Anastasios Arima acquired 138,720 shares of the firm’s stock in a transaction that occurred on Friday, July 10th. The shares were bought at an average price of $3.58 per share, with a total value of $496,617.60. Following the completion of the purchase, the chief executive officer directly owned 12,455,502 shares in the company, valued at $44,590,697.16. The trade was a 1.13% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 663,720 shares of company stock worth $2,379,118 over the last quarter.

Institutional Trading of IperionX

A number of institutional investors have recently modified their holdings of IPX. GAMMA Investing LLC increased its position in shares of IperionX by 40.3% during the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock worth $50,000 after purchasing an additional 483 shares in the last quarter. JPMorgan Chase & Co. acquired a new stake in shares of IperionX in the 2nd quarter worth $66,000. State of Tennessee Department of Treasury acquired a new stake in shares of IperionX in the 4th quarter worth $119,000. DV Equities LLC purchased a new position in IperionX during the 4th quarter worth $178,000. Finally, Man Group plc purchased a new position in IperionX during the 4th quarter worth $257,000. 2.76% of the stock is currently owned by institutional investors.

About IperionX

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

Featured Articles

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.